Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)

被引:7
作者
Kileel, Emma M. [1 ]
Malvestutto, Carlos D. [2 ]
Lo, Janet [1 ]
Fitch, Kathleen, V [1 ]
Fichtenbaum, Carl J. [3 ]
Aberg, Judith A. [4 ]
Zanni, Markella, V [1 ]
Martinez, Esteban [5 ,6 ]
Okeke, Nwora Lance [7 ,8 ]
Kumar, Princy [9 ]
Joao, Esau [10 ]
Bares, Sara H. [11 ]
Berrner, Daniel [12 ]
Smieja, Marek [13 ]
Roa, Jhoanna C. [14 ]
McCallum, Sara [1 ]
Douglas, Pamela S. [15 ]
Ribaudo, Heather J. [16 ]
Grinspoon, Steven K. [1 ,17 ,18 ]
机构
[1] Harvard Med Sch, Massachusetts Gen Hosp, Metab Unit, Boston, MA USA
[2] Ohio State Univ, Med Ctr, Div Infect Dis, Columbus, OH USA
[3] Univ Cincinnati, Div Infect Dis, Coll Med, Cincinnati, OH USA
[4] Icahn Sch Med Mt Sinai, Div Infect Dis, New York, NY USA
[5] Hosp Clin Barcelona, Infect Dis Serv, Barcelona, Spain
[6] Univ Barcelona, Barcelona, Spain
[7] Duke Univ, Sch Med, Dept Populat Hlth Sci, Durham, NC USA
[8] Duke Univ, Dept Med, Sch Med, Durham, NC USA
[9] Georgetown Univ, Div Infect Dis & Travel Med, Sch Med, Washington, DC USA
[10] Hosp Fed Servidores Estado, Infect Dis Dept, Rio De Janeiro, Brazil
[11] Univ Nebraska Med Ctr, Div Infect Dis, Omaha, NE USA
[12] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, San Francisco, CA USA
[13] McMaster Univ, Div Pathol & Mol Med, Hamilton, ON, Canada
[14] DLH Corp, Silver Spring, MD USA
[15] Duke Univ, Sch Med, Res Inst, Durham, NC USA
[16] Harvard TH Chan Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA USA
[17] Harvard Univ, Sch Med, 55 Fruit St,5LON207, Boston, MA 02114 USA
[18] Massachusetts Gen Hosp, Dept Med, 55 Fruit St,5LON207, Boston, MA 02114 USA
关键词
integrase strand transfer inhibitors (INSTIs); weight; body mass index (BMI); HIV;
D O I
10.1093/cid/ciad107
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Over 2-years of follow-up, integrase strand transfer inhibitor (INSTI)-use was associated with weight gain among those on an INSTI <2 years at entry (+0.27 kg/m(2)/year; 95% confidence interval [CI], .22 to .33 vs +0.17 kg/m(2)/year; 95% CI, .12 to .23; P = .01), but not those on an entry INSTI >2 years.
引用
收藏
页码:2010 / 2013
页数:4
相关论文
共 6 条
[1]   Weight and Metabolic Changes After Switching From Tenofovir Alafenamide (TAF)/Emtricitabine (FTC) plus Dolutegravir (DTG), Tenofovir Disoproxil Fumarate (TDF)/FTC plus DTG, and TDF/FTC/Efavirenz (EFV) to TDF/Lamivudine (3TC)/DTG [J].
Bosch, Bronwyn ;
Akpomiemie, Godspower ;
Chandiwana, Nomathemba ;
Sokhela, Simiso ;
Hill, Andrew ;
McCann, Kaitlyn ;
Qavi, Ambar ;
Mirchandani, Manya ;
Venter, Willem Daniel Francois .
CLINICAL INFECTIOUS DISEASES, 2023, 76 (08) :1492-1495
[2]   Leveraging a Landmark Trial of Primary Cardiovascular Disease Prevention in Human Immunodeficiency Virus: Introduction From the REPRIEVE Coprincipal Investigators [J].
Grinspoon, Steven K. ;
Douglas, Pamela S. ;
Hoffmann, Udo ;
Ribaudo, Heather J. .
JOURNAL OF INFECTIOUS DISEASES, 2020, 222 :S1-S7
[3]   Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) [J].
Grinspoon, Steven K. ;
Fitch, Kathleen V. ;
Overton, Edgar Turner ;
Fichtenbaum, Carl J. ;
Zanni, Markella V. ;
Aberg, Judith A. ;
Malvestutto, Carlos ;
Lu, Michael T. ;
Currier, Judith S. ;
Sponseller, Craig A. ;
Waclawiw, Myron ;
Alston-Smith, Beverly ;
Cooper-Arnold, Katharine ;
Klingman, Karin L. ;
Desvigne-Nickens, Patrice ;
Hoffmann, Udo ;
Ribaudo, Heather J. ;
Douglas, Pamela S. .
AMERICAN HEART JOURNAL, 2019, 212 :23-35
[4]   Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus [J].
Kileel, Emma M. ;
Lo, Janet ;
Malvestutto, Carlos ;
Fitch, Kathleen, V ;
Zanni, Markella, V ;
Fichtenbaum, Carl J. ;
Overton, Edgar T. ;
Okeke, Nwora Lance ;
Kumar, Princy ;
Joao, Esau ;
Aberg, Judith A. ;
Martinez, Esteban ;
Currier, Judith S. ;
Douglas, Pamela S. ;
Ribaudo, Heather J. ;
Grinspoon, Steven K. .
OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (12)
[5]   Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials [J].
Sax, Paul E. ;
Erlandson, Kristine M. ;
Lake, Jordan E. ;
Mccomsey, Grace A. ;
Orkin, Chloe ;
Esser, Stefan ;
Brown, Todd T. ;
Rockstroh, Jurgen K. ;
Wei, Xuelian ;
Carter, Christoph C. ;
Zhong, Lijie ;
Brainard, Diana M. ;
Melbourne, Kathleen ;
Das, Moupali ;
Stellbrink, Hans-Jurgen ;
Post, Frank A. ;
Waters, Laura ;
Koethe, John R. .
CLINICAL INFECTIOUS DISEASES, 2020, 71 (06) :1379-1389
[6]  
Venter WDF., 2022, Final week 192 results from the ADVANCE trial: first-line TAF/FTC/DTG, TDF/FTC/DTG versus TDF/FTC/EFV-weight gain